Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Helicobacter pylori. Update 2002].

M J Schuster1

  • 1Medizinische Klinik, Fachbereich Gastroenterologie, Städtische Kliniken Esslingen, Akademisches Lehrkrankenhaus der Universität Tübingen.

Praxis
|January 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Complications of liver cirrhosis: portal hypertension, gastroesophageal varices and ascites].

Praxis·2003
Same author

Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice.

Bioconjugate chemistry·1999
Same author

Chimeric oligonucleotides: an exciting answer that raises more questions.

Hepatology (Baltimore, Md.)·1998
Same author

Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned!

Gastroenterology·1997
Same author

[Abdominal colic, petechiae, arthralgia amd tar stools in a 56-year-old kidney transplant patient].

Der Internist·1996
Same author

Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.

Kidney international·1993
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Helicobacter pylori (H. pylori) infection is a primary cause of peptic ulcers and gastric cancers. Standardized diagnosis and a week-long eradication therapy using proton pump inhibitors and antibiotics are recommended for specific conditions.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Oncology

Background:

  • Helicobacter pylori infection is a leading cause of peptic ulcer disease, gastric adenocarcinoma, and MALT lymphoma.
  • Research is ongoing to understand its role in functional dyspepsia and gastro-esophageal reflux disease.
  • The interaction between H. pylori and NSAIDs is also an active area of investigation.

Purpose of the Study:

  • To outline the established indications for H. pylori eradication therapy.
  • To describe the standardized diagnostic and therapeutic approaches for H. pylori infection.
  • To highlight the recommended first-line eradication regimens.

Main Methods:

  • Standardized diagnostic protocols for H. pylori infection.
  • Established criteria for initiating eradication therapy.

Related Experiment Videos

  • Recommended first-line eradication regimens comprising a proton pump inhibitor, clarithromycin, and amoxicillin or metronidazole for one week.
  • Main Results:

    • H. pylori infection is a significant risk factor for several gastrointestinal diseases.
    • Established indications for eradication include peptic ulcer disease, gastric MALT lymphoma, and gastric cancer.
    • Atrophic gastritis and family history of gastric cancer are also accepted indications for treatment.

    Conclusions:

    • Diagnosis and eradication therapy for H. pylori infection are standardized.
    • A one-week course of proton pump inhibitor-based triple therapy is the recommended regimen.
    • Eradication is crucial for managing H. pylori-associated gastrointestinal conditions and preventing precancerous lesions.